The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Anti‐CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat
Abstract
We investigated the effect of an anti‐CD11b monoclonal antibody (1B6c) on ischemic cell damage after transient middle cerebral artery occlusion. We divided animals into three groups: MAb 1 group (n = 5)—rats were subjected to 2 hours of transient occlusion and 1B6c (1 mg/kg) was administered intravenously at 0 and 22 hours of reperfusion; MAb 2 group (n = 5)—same experimental protocol as MAb 1 group, except that the initial dose of 1B6c was increased to 2 mg/kg; and control group (n = 5)—same experimental protocol as MAb 2 group, except that an isotype‐matched control antibody was administered. Animals were weighed and tested for neurological function before and after occlusion of the middle cerebral artery. Forty‐six hours after reperfusion, brain sections were stained with hematoxylin and eosin for histology evaluation. We observed a significant reduction of weight loss and improvement in neurological function after ischemia in the MAb 2 animals compared to MAb 1 and vehicle‐treated animals (p < 0.05). The lesion volume was significantly smaller in the MAb 2 group (19.5 ± 1.9%) compared to MAb1 (29.9 ± 2.6%) and vehicletreated (34.2 ± 5.4%) group (p < 0.01). Tissue polymorphonuclear cell numbers were reduced in both 1B6c‐administered groups. Our data demonstrate that administration of anti‐CD11b antibody results in a dose‐dependent, significant functional improvement and reduction of ischemic cell damage after transient focal cerebral ischemia in the rat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463
Cited by
Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics
Barone, F. C., & Feuerstein, G. Z. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199908000-00001 · Cited by 930
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke
Yang, C., Hawkins, K. E., Doré, S., & Candelario-Jalil, E. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00136.2018 · Cited by 871
Molecular targets in cerebral ischemia for developing novel therapeutics
Mehta, S. L., Manhas, N., & Raghubir, R. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.11.003 · Cited by 708
Inducible Nitric Oxide Synthase Gene Expression in Brain following Cerebral Ischemia
Iadecola, C., Zhang, F., Xu, S., Casey, R., & Ross, M. E. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.47 · Cited by 469
The Role of Inflammation and Cytokines in Brain Injury
ARVIN, B., NEVILLE, L. F., BARONE, F. C., & FEUERSTEIN, G. Z. (1996) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(95)00026-7 · Cited by 416
Metadata
- Authors
- Chen, H., Chopp, M., Zhang, R. L., Bodzin, G., Chen, Q., Rusche, J. R., & Todd, R. F.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1994-04
- Volume
- 35
- Issue
- 4
- Pages
- 458-463
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2025326202
- Cited by
- 226
- References
- 1
- FWCI
- 18.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti‐CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. https://app.cochat.ai/papers/10.1002/ana.410350414
- The paper
- Chen, H., Chopp, M., Zhang, R. L., Bodzin, G., Chen, Q., Rusche, J. R., & Todd, R. F. (1994). Anti‐CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Annals of Neurology. https://doi.org/10.1002/ana.410350414
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.